Loading
A phase 2 trial of cisplatin, carboplatin, pemetrexed, pembrolizumab and other drugs in lung cancer, run by H. Lee Moffitt Cancer Center and Research Institute, now recruiting.
Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC is a phase 2, interventional study registered as NCT06745882 by H. Lee Moffitt Cancer Center and Research Institute, with a registry enrolment figure of 318 participants, started 2025-06-13 and due to reach its primary completion in 2030-01. Interventions recorded: Cisplatin; Carboplatin; Pemetrexed; Pembrolizumab; Abraxane; Paclitaxel. Conditions listed: Non-small Cell Lung Cancer. Primary outcome: Cohort 1: Real World Overall Survival (rwOS); Cohort 2 Arm A: Progression Free Survival (PFS); Cohort 2 Arm B: Progression Free Survival (PFS). Lung eligibility wording from the registry: "* Have histologically or cytologically confirmed, advanced/metastatic NSCLC". Sites: United States. No results are recorded here; the registry entry is the source.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Nab-paclitaxel, Pemetrexed, Lung cancer trials open today (registry snapshot), Paclitaxel / nab-paclitaxel and the tag lung-deep-dive.
Shares Nab-paclitaxel, Lung cancer trials open today (registry snapshot), Paclitaxel / nab-paclitaxel, Platinum agents and the tag lung-deep-dive.
Shares Pemetrexed, Lung cancer trials open today (registry snapshot), Platinum agents, Carboplatin and the tag lung-deep-dive.
Shares Pemetrexed, Lung cancer trials open today (registry snapshot), Paclitaxel / nab-paclitaxel, Platinum agents and the tag lung-deep-dive.
Shares Nab-paclitaxel, Pemetrexed, Lung cancer trials open today (registry snapshot), Platinum agents and the tag lung-deep-dive.
Shares Pemetrexed, Lung cancer trials open today (registry snapshot), Platinum agents, Cisplatin and the tag lung-deep-dive.
Shares Pemetrexed, Lung cancer trials open today (registry snapshot), Platinum agents, Carboplatin and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Paclitaxel / nab-paclitaxel, Platinum agents, Cisplatin and the tag lung-deep-dive.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/